Planet 13 Holdings (PLNH) Profit After Tax (2021 - 2026)
Planet 13 Holdings' (PLNH) quarterly Profit After Tax came in at -$8.1 million in Q1 2026, down 22.43% year-on-year from -$10.4 million in Q1 2025, and down 48928.72% on a QoQ basis from $16580.0 in Q4 2025.
Planet 13 Holdings (PLNH) Profit After Tax (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has 6 years of Profit After Tax data on file, last reported at -$8.1 million in Q1 2026.
- On a quarterly basis, Profit After Tax fell 22.43% year-over-year to -$8.1 million in Q1 2026; TTM through Mar 2026 was -$56.2 million, a 40.67% decrease from a year earlier, with the FY2025 full-year figure at -$59.3 million, down 24.04% from the prior year.
- Profit After Tax for Q1 2026 stood at -$8.1 million, down from $16580.0 in the prior quarter.
- Over the last five years, Profit After Tax for PLNH reached as high as $16580.0 in Q4 2025 and fell as low as -$46.3 million in Q3 2023.
- Historically, Profit After Tax has averaged -$13.1 million across 5 years, with a median of -$6.6 million in 2025.
- On a YoY basis, Profit After Tax climbed as much as 100.06% in 2025 and fell as far as 1140.68% in 2025.
- Year by year, Profit After Tax stood at -$42.1 million in 2022, then soared by 78.21% to -$9.2 million in 2023, then tumbled by 188.31% to -$26.4 million in 2024, then jumped by 100.06% to $16580.0 in 2025, then tumbled by 48928.72% to -$8.1 million in 2026.
- Per Business Quant data, the three most recent Profit After Tax figures were -$8.1 million in Q1 2026, $16580.0 in Q4 2025, and -$41.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 369.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.35 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 274.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Planet 13 Holdings | 39.35 Mn | 23.09 Mn | 9.41 Mn | -8.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.10 Mn |
| Dec 31, 2025 | 16,580.00 |
| Sep 30, 2025 | -41.25 Mn |
| Jun 30, 2025 | -6.83 Mn |
| Mar 31, 2025 | -6.61 Mn |
| Dec 31, 2024 | -26.44 Mn |
| Sep 30, 2024 | -3.32 Mn |
| Jun 30, 2024 | -3.54 Mn |
| Mar 31, 2024 | -3.67 Mn |
| Dec 31, 2023 | -9.17 Mn |
| Sep 30, 2023 | -46.25 Mn |
| Jun 30, 2023 | -4.62 Mn |
| Mar 31, 2023 | -8.48 Mn |
| Dec 31, 2022 | -42.09 Mn |
| Sep 30, 2022 | -6.32 Mn |
| Jun 30, 2022 | -1.82 Mn |
| Mar 31, 2022 | -3.71 Mn |
| Dec 31, 2021 | -4.01 Mn |
| Sep 30, 2021 | -2.74 Mn |
| Jun 30, 2021 | -5.56 Mn |